Breaking News

Bayer Drops Out in the Race for Schiff

November 20, 2012

According to published reports, Bayer AG has ceased its pursuit of Schiff Nutrition International Inc., ending speculation that the deal was poised to become the industry’s most expensive acquisition.

Late last month German drugmaker Bayer announced its intent to buy Schiff for $34 a share, or about $1.1 billion including net debt, according to Bloomberg. The situation grew interesting when Reckitt Benckiser Group Plc made a surprise offer of $42 a share, or about $1.4 billion.

In a filing with the U.S. Securities and Exchange Commission Bayer said that a competitive bidding process “would result in a price outside Bayer’s set financial criteria.”

Related Market Segments:

  • Nutritional Minerals: Tried & True

    Nutritional Minerals: Tried & True

    Lisa Olivo, Associate Editor||January 3, 2017
    Among the most elementary ingredients in the nutraceuticals space, minerals continue to benefit public health.

  • Healthy Snack Trends to Chew On

    Healthy Snack Trends to Chew On

    Amanda Baltazar, Contributing Writer||January 3, 2017
    Consumers are seeking more positive attributes and fewer ingredients from their snacks and nutrition bars.

  • Herbalife: A Nutrition Leader in Transition

    Herbalife: A Nutrition Leader in Transition

    Sean Moloughney, Editor||January 3, 2017
    The company remains committed to high-quality products that support consumers’ wellness goals.